A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 85, Issue 1, 1998, Pages 64-73

  Glueck, C J ^a   McMahon, R E ^b   Bouquot, J E ^a   Tracy, T ^a   Sieve Smith, L ^a   Wang, P ^a  

^a JEWISH HOSPITAL   (United States)

^b Oral Surgery Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANTICOAGULANT AGENT; STANOZOLOL; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; BONE NECROSIS; CLINICAL TRIAL; CONTROLLED STUDY; FACE PAIN; FEMALE; FIBRINOLYSIS; HUMAN; JAW DISEASE; MALE; MIDDLE AGED; PILOT STUDY; THROMBOPHILIA;

ADULT; AGED; ANABOLIC AGENTS; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; FACIAL PAIN; FEMALE; FIBRINOLYSIS; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; OSTEONECROSIS; PILOT PROJECTS; STANOZOLOL; THROMBOPHILIA; WARFARIN;

EID: 0031606819     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90400-0     Document Type: Article

References (39)

1. Bouquot JE, Roberts AM, Person P, Christian J. Neuralgiainducing cavitational osteonecrosis (NICO): osteomyelitis in 224 jawbone samples from patients with facial neuralgia. Oral Surg Oral Med Oral Pathol 1992;73:307-19.
2. Bouquot JE. Neuralgia-inducing cavitational osteonecrosis. In: Neville BW, Damm DD, Allen CM, Bouquot JE, editors. Oral & Maxillofacial Pathology. Philadelphia: Saunders; 1995. p. 631-2.
3. Gruppo R, Glueck CJ, McMahon RE, Bouquot J, Becker A, Tracy T, et al. Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis: pathophysiology of osteonecrosis of the jaw. J Lab Clin Med 1996;127:481-9.
4. Glueck CJ, McMahon RE, Bouquot J, Stroop D, Tracy T, Wang P. Pathophysiology of osteonecrosis of the jaw: thrombophilia and hypofibrinolysis. Oral Surg Oral Med Oral Pathol 1996;81: 557-66.
5. Glueck CJ, Freiberg R, Glueck HI, Henderson C, Welch M, Tracy T, et al. Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematology 1994;45:156-66.
6. Glueck CJ, Freiberg R, Glueck HI, Tracy T, Stroop D, Hamer T. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein (a), and therapy with stanozolol. Am J Hematology 1995;48:213-20.
7. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P. Thrombophilia, hypofibrinolysis, and osteonecrosis. Clinical Orthopedics 1997;334:43-56.
8. Glueck CJ, Glueck HI, Greenfield D, Freiberg R, Kahn A, Hamer T, et al. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes dis-ease. Pediatric Research 1994;35:383-8.
9. Glueck CJ, Glueck HI, Mieczkowski L, Tracy T, Speirs J, Stroop D. Familial high plasminogen activator inhibitor with hypofibrinolysis: a new pathophysiologic cause of osteonecrosis? Thrombosis Haemostasis 1993;69:460-5.
10. Glueck CJ, Glueck HI, Welch M, Freiberg R, Stroop D, Hamer T, et al. Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor. Thrombosis Haemostasis 1994;71:195-8.
11. Glueck CJ, Freiberg R, Tracy T, Wang P. Thrombophilia, hypofibrinolysis, and reversible osteonecrosis [Abstract]. Journal of Investigative Medicine 1996;44:357A.
12. Glueck CJ, Freiberg R, Gruppo R, Crawford A, Roy D, Brandt G, et al. Thrombophilia and hypofibrinolysis: reversible pathogenetic etiologies of osteonecrosis in adults and in children (Legg-Perthes disease). In: Urbaniak J, Jones JP, editors. Osteonecrosis: etiology, diagnosis, and treatment. Resemont, IL: American Academy of Orthopedic Surgeons; 1997. p. 105-10.
13. Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone and Joint Surg 1996;78A:3-13.
14. Ratner E, Person P, Kleinman DJ, Shklar G, Socransky S. Jawbone cavities and trigeminal and atypical facial neuralgia. Oral Surg Oral Med Oral Pathol 1979;48:3-20.
15. Ratner E, Langer B, Evins M. Alveolar cavitational osteopathosis. J Periodontol 1986;57:593-603.
16. Jiao X, Meng Q. The influence of pathological bone cavity of jawbone on the etiopathology of trigeminal neuralgia. Act Acad Med Sichuan 1981;12:243-7.
17. McMahon RE, Criep J, Marfurt C, Saxen M. Local anaesthetic effects in the presence of chronic osteomyelitis (necrosis) of the mandible: implications for localizing the etiologic site(s) of referred trigeminal pain, J Craniomand Pract 1995;13:212-26.
18. Bender IB. Factors influencing the radiographic appearance of bony lesions. J Endodontics 1996;23:5-11.
19. Ficat RP, Arlet J. Ischemia and necrosis of bone. Baltimore: Williams and Wilkins; 1980.
20. Arlet J, Mazieres B, editors. Bone circulation and bone necrosis. Heidelberg: Springer-Verlag; 1990.
21. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993;42:236-46.
22. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia. Metabolism 1993;42:1410-9.
23. Chapman CR, Syrjala KL. Measurement of pain. In: Bonica JJ, editor. The management of pain. Philadelphia-London: Lea and Febiger; 1990. p. 580-93.
24. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames, IA: Iowa State University Press; 1980.
25. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994;271:1609-14.
26. Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Becker A, et al. Resistance to activated protein C, Legg-Perthes disease, and thrombosis. Clinical Orthopedics 1997;338:139-52.
27. Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Becker A, et al. Familial resistance to activated protein C causing Legg-Perthes disease [Abstract]. Thrombosis-Haemostasis 1995;73: 1367.
28. Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Becker A, et al. Thrombophilia (resistance to activated protein C, low protein C or S) and hypofibrinolysis causing Legg-Perthes disease [Abstract]. Thrombosis-Haemostasis 1995;73:1362.
29. Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 1996;27:1721-3.
30. Deschiens MA, Conrad J, Horellou MH, Ameri A, Preter M, Chedru F, et al. Coagulation studies, Factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-30.
31. Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996;27:1731-3.
32. Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996;335:1816-27.
33. Macko RF, Ameriso SF, Barndt R, Clough W, Weinger JM, Fisher M. Precipitants of brain infarction: roles of preceding infection/inflammation and recent psychological stress. Stroke 1996;27:1999-2004.
34. Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernandez JA, Barndt R, et al. Impairments of the Protein C system and fibrinolysis in infection-associated stroke. Stroke 1996;27:2005-11.
35. Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke 1996;27:2204-6.
36. Choi IH, Lee DY, Chung CY, Rhyu KH, Park SY. Changes in coagulation-fibrinolysis system in Legg-Perthes disease: a preliminary report [Abstract]. Proceedings of the Pediatric Orthopedic Society of North America 1995;2:1.
37. Jones JP. Intravascular coagulation and osteonecrosis. Clin Orthop 1992;277:41-54.
38. Nilsson IM, Krook H, Sternby HH, Soderberg E, Soderstrom N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand 1961;169:323-7.
39. Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematology 1993;44:243-8.